Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice is organized by Clinical Care Options (CCO), LLC.,Released: August 03, 2022,Expiration: August 02, 2023,Goal:,The goal of this program is to improve the knowledge, confidence, and competence of learners in selecting individualized treatments for patients with indolent B-cell lymphomas.,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Order and interpret molecular profiling for appropriate patients with indolent B-cell lymphoma to guide therapy selection,• Select treatment regimens for patients with MZL and FL based on available clinical data, disease characteristics, and individual patient goals and preferences to optimize clinical outcomes,• Identify patients with indolent B-cell lymphoma who would likely benefit from enrollment on a clinical trial,• Mitigate, monitor, and manage adverse events associated with newer therapeutic regimens used in the treatment of indolent B-cell lymphomas,Additional details will be posted as soon as information is available.